Prostate Cancer Clinical Trials Consortium   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: New York NY United States (2005)

Organization Overview

First Clinical Trial
2006
NCT00405574
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Prostate Cancer Clinical Trials Consortium

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 1)

Carcinoma (Phase 2)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 12